Have a personal or library account? Click to login
A comparison between the continual reassessment method and D-optimum design for dose finding in phase I clinical trials Cover

A comparison between the continual reassessment method and D-optimum design for dose finding in phase I clinical trials

Biometrical Letters
Volume 53 (2016): Issue 2 (December 2016)
By: M. Iftakhar Alam  
Open Access
|Dec 2016
DOI: https://doi.org/10.1515/bile-2016-0006 | Journal eISSN: 2199-577X | Journal ISSN: 1896-3811
Journal RSS Feed
Language: English
Page range: 69 - 82
Published on: Dec 10, 2016
Published by: Polish Biometric Society
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year
Keywords:
Dose finding studies,
Phase I trial,
Maximum tolerated dose,
Continual reassessment method,
-optimum design
Related subjects:
Life sciences,
Bioinformatics,
Life sciences, other,
Mathematics,
Probability and statistics,
Applied mathematics

© 2016 M. Iftakhar Alam, published by Polish Biometric Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Volume 53 (2016): Issue 2 (December 2016)Next article